TickerFacts.

Opus Genetics, Inc. (IRD): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Older than the company's other figures. The latest EBITDA is for the year ended 2019-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$4.15M
Year ended 2019-12-31
2009-12-31: -$6.42M2010-12-31: -$10.26M2011-12-31: -$16.09M2012-12-31: -$6.54M2013-12-31: -$7.94M2014-12-31: -$13.24M2015-12-31: -$18.24M2016-12-31: -$16.38M2017-12-31: -$17.31M2018-12-31: -$20.49M2019-12-31: -$4.15M-$4.15M
2009-12-31 EBITDA (USD) 2019-12-31
Period endedEBITDAChange YoYSource filing
2019-12-31-$4.15Mn/m2021-03-11, From 2019-01-01
2018-12-31-$20.49Mn/m2020-02-21, From 2018-01-01
2017-12-31-$17.31Mn/m2019-03-07, From 2017-01-01
2016-12-31-$16.38Mn/m2018-03-09, From 2016-01-01
2015-12-31-$18.24Mn/m2018-03-09, From 2015-01-01
2014-12-31-$13.24Mn/m2017-02-24, From 2014-01-01
2013-12-31-$7.94Mn/m2016-03-14, From 2013-01-01
2012-12-31-$6.54Mn/m2014-03-21, From 2012-01-01
2011-12-31-$16.09Mn/m2013-03-22, From 2011-01-01
2010-12-31-$10.26Mn/m2012-03-16, From 2010-01-01
2009-12-31-$6.42Mn/a2012-03-16, From 2009-01-01